Our findings highlight the critical role of various laboratory biomarkers, including hematological indices such as Neutrophil count and NLR as well as inflammation biomarkers like CRP and serum IL-10, in monitoring the severity of ARDS in COVID-19 patients. This evidence concerns the gene IL10 and COVID-19.